Later, Wang et al. [202] reported that a combination of BRD4 and HDAC3 inhibitors synergistically halted glioma stem cell growth by inhibiting the GLI1/IL6/STAT3 signaling pathway, suggesting that the repertoire of BRD4-mediated signaling might be more comprehensive. This evidence concerns the gene STAT3 and central nervous system cancer.